Information of patent applications filed at local or international levels, that are contributed by the users of PODB as being relevant to this medicine
Please note that PODB does not provide and guarantee the comprehensive patent landscape in all countries.
*For more knowledge of patent search, please refer to the tutorial Step 2: Patent Search & Analysis
*For more information of the patent landscape on medicines, please also refer to WHO patent landscape reports, UNITAID patent landscape reports, Medicines Patent Pool Patent Status Database
The table includes information of patent applications as filed in different countries, that are contributed by PODB users as being seen as relevant to this medicine.
|Country||Filing date||Priority date||Applicant||National number||International number||Status||Patent type||More info|
|India||21-04-1997||Novartis International AG||805/MAS/1997||WO/1997/40029||Abandoned||Molecules||View/Comment|
|India||01-11-2006||Bristol-Myers Squibb Company||6425/DELNP/2006||WO/2005/108349||Rejected||Processes||View/Comment|
|India||01-05-2009||Bristol-Myers Squibb Company||2933/DELNP/2009 (Divisional of 6425/DELNP/2006)||WO/2005/108349||Under Examination||Processes||View/Comment|
|Brazil||03-05-2005||Bristol-Myers Squibb Company (US)||PI0509595-6||WO2005108349||Under Examination||Molecules||View/Comment|
Information related to relevant oppositions from around the world.
The table includes oppositions aimed at contesting patents covering this drug. Note that at the country level, several patent applications can cover the same drug.
Please pay attention not only to the patent opposition, but also to the patent application it relates to, see column "Related Patent Application". To better identify similarities, the column "Patent Type" indicates a general classification of the patent. Arguments used to contest a specific type of patent may apply for another that fits in the same category.
|Country||Date||Who Filed||Opposition type||Opposition status||Patent type||Related patent application||More info|
|India||02-08-2006||Indian Network of People Living with HIV/AIDS (INP+) and Karnataka Network of Positive People (KNP+)||Pre-Grant||Abandoned after opposition||Molecules||805/MAS/1997||View/Comment|
|India||14-11-2011||Cipla Ltd.||Pre-Grant||Under Examination||Processes||2933/DELNP/2009 (Divisional of 6425/DELNP/2006)||View/Comment|
|India||24-08-2009||Matrix Laboratories Ltd.||Pre-Grant||Awaiting Examination||Molecules||WO/2013/176772||View/Comment|
|India||07-06-2013||Matrix Laboratories Ltd & Indian Network of People Living with HIV/AIDS (INP+)||Pre-Grant||Under Examination||Molecules||310/CHE/2007 (Divisional of 805/MAS/1997)||View/Comment|
|Brazil||14-11-2019||GTPI - Grupo de Trabalho sobre Propriedade Intelectual||Post-Grant||Under Examination||Polymorphs||PI0509595-6||View/Comment|
Patent Office Decisions
This table showcases the final ruling of patent offices over cases where patents have been opposed.
To better identify the case, the number of the patent application is provided in the table below.
Other Useful Resources
Information related to either legal proceedings or other useful points of information that could aid in the building of a strong patent opposition.
Additional documents that may inform the process of building a patent opposition.
|Type of document||Title||Date||Country||More info|
|Disclosure of patent application landscape for WO2005/108349||Form 3||01-05-2009||View/Comment|